ConductScience.org, home

Paper41844740

CHD1L promotes testicular cancer progression through epigenetic activation of the CXCR6/PI3K/AKT pathway.

Zhao Y and 5 others. Sci Rep, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. CHD1L promotes testicular cancer progression through epigenetic activation of the CXCR6/PI3K/AKT pathway. Papers, record 41844740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41844740

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CHD1L promotes testicular cancer progression through epigenetic activation of the CXCR6/PI3K/AKT pathway.
PubMed
Journal
Sci Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhao YYang
2Yan HHao
3Chen XXinda
4Zhang XXiaolin
5Lu MMujun
6Zhang MMing

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Testicular NeoplasmsMajor topic
Proto-Oncogene Proteins c-aktMajor topic
Phosphatidylinositol 3-KinasesMajor topic
Epigenesis, GeneticMajor topic
DNA HelicasesMajor topic
DNA-Binding ProteinsMajor topic
Receptors, CXCR6Major topic
Male
Humans
Animals
Signal Transduction
Mice
Gene Expression Regulation, Neoplastic
Disease Progression
Cell Line, Tumor
Cell Proliferation
Cell Movement

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82171611, 81971376National Natural Science Foundation of China-China Academy of General Technology Joint Fund for Basic ResearchPubMed
2022YFC2804300National Key Research and Development Program of ChinaPubMed
21ZR14389001Shanghai Science and Technology Commission Research ProjectPubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125371726Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma.Exp Ther Med2014https://conductscience.org/library/papers/25371726PubMed
234298782CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling.Cancers (Basel)2021https://conductscience.org/library/papers/34298782PubMed
333800554The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.Int J Mol Sci2021https://conductscience.org/library/papers/33800554PubMed
430577487The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors.Cancers (Basel)2018https://conductscience.org/library/papers/30577487PubMed
524242335Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.Int J Cancer2014https://conductscience.org/library/papers/24242335PubMed
633538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
721816936CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis.J Am Soc Nephrol2011https://conductscience.org/library/papers/21816936PubMed
832164473Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targets.Expert Rev Anticancer Ther2020https://conductscience.org/library/papers/32164473PubMed
920335658CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.J Clin Invest2010https://conductscience.org/library/papers/20335658PubMed
1020043168Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors.World J Urol2010https://conductscience.org/library/papers/20043168PubMed
1133729863Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.J Clin Oncol2021https://conductscience.org/library/papers/33729863PubMed
1218293410Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas.Glia2008https://conductscience.org/library/papers/18293410PubMed
1330060750Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.Mol Cancer2018https://conductscience.org/library/papers/30060750PubMed
1430850015Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.Clin Epigenetics2019https://conductscience.org/library/papers/30850015PubMed
1526559672CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma.Endocr Relat Cancer2016https://conductscience.org/library/papers/26559672PubMed
1631324498International Trends in the Incidence of Testicular Cancer: Lessons from 35 Years and 41 Countries.Eur Urol2019https://conductscience.org/library/papers/31324498PubMed
1719576697First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs).Cancer Treat Rev2009https://conductscience.org/library/papers/19576697PubMed
1823746766CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.J Surg Res2013https://conductscience.org/library/papers/23746766PubMed
1932593915Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities.Cancer Treat Rev2020https://conductscience.org/library/papers/32593915PubMed
2034667158Histone demethylase KDM4D inhibition suppresses renal cancer progression and angiogenesis through JAG1 signaling.Cell Death Discov2021https://conductscience.org/library/papers/34667158PubMed

See all 40 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42353640In Vitro Evaluation of Combination Therapy with Doxorubicin and Quercetin for Uveal Melanoma.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42353640

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CHD1L9557PubTator's text mininghttps://conductscience.org/library/genes/9557NCBI Gene
CXCR610663PubTator's text mininghttps://conductscience.org/library/genes/10663NCBI Gene
PIK3CB5291PubTator's text mininghttps://conductscience.org/library/genes/5291NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41844740

GET https://conductscience.org/api/papers/v1/41844740/references?page=2